The use of metered-dose inhalers (MDIs) for the treatment of diseases such as asthma has become popular since their introduction in the late 1950s. MDIs come in the form of nasal or oral inhalers and are much appreciated by patients who depend on them for their treatment. MDIs are designed to deliver precise/accurate and reproducible doses of the drug to the lungs or nose. This is crucial as patients rely on their inhaler to deliver the required medication at often crucial times when physical strength may be very low.
Container closure integrity (CCI) defects might be highly hazardous to patients, if not detected prior to administration.
The generics market has taken off in recent years due to numerous patent expirations for brand-name companies. In light of this, pharmaceutical manufacturers, insurance companies and consumers, in search of significant cost savings, have turned towards the generics industry.
Organizations that consistently develop and launch new products efficiently in an environment of increasing regulatory scrutiny, successfully manage regulatory risk. By Mike Kuehne, ACSYS, Inc.
Implementing a vision inspection solution to monitor the quality and security of your personal care product is an effective quality control method that allows processes to reach maximum throughput and productivity. By Wayne Eide
For those who haven’t checked their watch lately we’d like to remind you there are only two years until California’s serialization mandates take effect. By John DiPalo, Chief Operations Officer
This white paper focuses on optical character recognition (OCR) and its extensive use in pharmaceutical packaging for compliance with date and lot tracking regulations. Machine vision OCR helps manufacturers adhere to these mandates in an effi cient and cost-effective manner, and can also improve line performance.